Skip to main content
Frontiers in Molecular Biosciences logoLink to Frontiers in Molecular Biosciences
. 2016 Nov 9;3:73. doi: 10.3389/fmolb.2016.00073

Bacterial RNA Polymerase-DNA Interaction—The Driving Force of Gene Expression and the Target for Drug Action

Jookyung Lee 1, Sergei Borukhov 1,*
PMCID: PMC5101437  PMID: 27882317

Abstract

DNA-dependent multisubunit RNA polymerase (RNAP) is the key enzyme of gene expression and a target of regulation in all kingdoms of life. It is a complex multifunctional molecular machine which, unlike other DNA-binding proteins, engages in extensive and dynamic interactions (both specific and nonspecific) with DNA, and maintains them over a distance. These interactions are controlled by DNA sequences, DNA topology, and a host of regulatory factors. Here, we summarize key recent structural and biochemical studies that elucidate the fine details of RNAP-DNA interactions during initiation. The findings of these studies help unravel the molecular mechanisms of promoter recognition and open complex formation, initiation of transcript synthesis and promoter escape. We also discuss most current advances in the studies of drugs that specifically target RNAP-DNA interactions during transcription initiation and elongation.

Keywords: RNA polymerase, transcription, promoter recognition, transcription initiation, transcription factors

Introduction

Bacterial multisubunit DNA-dependent RNA polymerase (RNAP) is the key enzyme of gene expression and a target of regulation. It is responsible for the synthesis of all RNAs in the cell using ribonucleoside triphosphates (NTPs) substrates. The core enzyme consists of five evolutionarily conserved subunits (α2ββ′ω) with a total molecular weight of ~380 kDa (Borukhov and Nudler, 2008). Although catalytically active, the core enzyme alone is unable to recognize specific promoter sequences, or melt the DNA and initiate transcription. For this, it associates with one of several specificity factors, σ (20~70 kDa), to form RNAP holoenzyme (α2ββ′ωσ) (Murakami and Darst, 2003; Decker and Hinton, 2013). In all bacterial species, most housekeeping genes are transcribed by holoenzyme of one major sigma factor, such as σ70 in E. coli or σA in Thermus thermophilus. Binding of alternative σ factors generates multiple forms of holoenzyme that can utilize different classes of promoters under various growth conditions and in response to environmental cues. The number of σ factors in different bacterial species varies widely from 1 in Mycoplasma genitalium to 7 in E. coli to 63 in Streptomyces coelicolor. Many regulatory factors besides σ can modulate RNAP's ability to recognize promoters and initiate transcription, modify its enzymatic functions and properties (Gruber and Gross, 2003).

Overview of RNAP structure

In the last 16 years, a wealth of structural information on bacterial RNAPs core and holoenzymes was made available. Initially, the high resolution (2.5~4.5 Å) X-ray crystal structures of RNAP and RNAP complexes with nucleic acids, regulatory factors, and small-molecule inhibitors were obtained using thermophilic organisms, T. thermophilus (Tth) and T. aquaticus (Taq). Beginning in 2013, high-resolution structures of E. coil (Eco) RNAP holoenzyme and its complexes with nucleic acid and inhibitors began to emerge from several groups. Altogether more than 24 high resolution structures of RNAP/RNAP complexes to date have been deposited to database (Zhang et al., 2012, 2014; Bae et al., 2013, 2015a,b), (Bae et al., 2015c; Molodtsov et al., 2013, 2015; Murakami, 2013; Sarkar et al., 2013), (Zuo et al., 2013; Basu et al., 2014; Degen et al., 2014; Feng et al., 2015, 2016; Liu et al., 2015, 2016; Yang et al., 2015b; Zuo and Steitz, 2015). These include: the structures of Taq core; Eco core with transcription factor, RapA; Taq, Tth, and Eco holoenzymes and open promoter complexes; Tth ternary elongation complexes with and without transcription factors (Gfh1, GreA); Taq and Tth RNAP complexes with small-molecule inhibitors and antibiotics. Structural data compilation was also aided by high-resolution structures (1.8–2.9 Å) of sub-domains of Eco RNAP subunits β′, α, and σ, and their complexes with DNA and regulatory factors. For a comprehensive list of currently available bacterial RNAP structures, see the recent review (Murakami, 2015). Together with information gained from a wide range of biochemical, biophysical, and genetic studies, these data refine our understanding of bacterial RNAP structure-function and provide a broad view of transcription process and its regulation.

The overall structure of a bacterial RNAP core enzyme resembles a crab claw, with the two clamps representing β and β′ subunits (Figure 1). The clamps are joined at the base by the N-terminal domains of σ-dimer (αNTDs) serving as a platform for RNAP assembly. σI-NTD and αII-NTD contact mostly β and β′ subunits, respectively. The C-terminal domains of α-dimer (αCTD), each tethered to NTD through a flexible linker, project out from the side of RNAP facing upstream DNA. The large internal cleft between β and β′ clamps is partitioned into the main “primary channel” that accommodates downstream dsDNA and RNA-DNA hybrid; the “secondary channel,” which serves as the site for NTP entry; and the “RNA exit channel” which is involved in RNA/DNA hybrid strand separation and interactions with RNA hairpins during pausing and termination. The active center is located on the back wall of the primary channel, at the center of the claw, where the catalytic loop with three aspartates holding essential Mg2+ ion resides. A long α-helical “bridge” (bridge helix, BH) connecting the β and β′ clamps, the two flexible α-helices of the “trigger” loop (TL), and an extended loop (F-loop), together with the catalytic loop, comprise the active center (reviewed in Nudler, 2009). The ω subunit is bound near the β′ C-terminus at the bottom pincer, serving as a β′ chaperone.

Figure 1.

Figure 1

Structural overview of RNAP core. Structure of Taq RNAP core (PDB:1HQM; Zhang et al., 1999) shown in ribbons in two rotational views, using Molsoft ICM Pro program. Left panel, 2° channel view; right panel, main channel view. The structure is represented as colored ribbons (αI, olive; αII, light gray; β, yellow; β′, cyan; ω, blue) with important domains and structural elements indicated. The directions of primary, secondary and RNA exit channels are indicated by large arrows. Mg2+ ion is shown as a small magenta sphere. The structures of β′ trigger loop (TL), β′ rudder, β′ lid, β′ zipper, and β′ switch-2 regions are modeled using the structure of Tth holoenzyme (PDB: 1IW7; Vassylyev et al., 2002). The Tth β′ nonconserved domain (NCD1, G164-S449) is not shown.

In the structure of σ70-holoenzyme, the bulk of the σ subunit (domains σ1–σ3) is bound on the core surface at the entrance to the major cleft, except for the linker connecting σ domains 3 and 4 (σ3–4 linker containing conserved region σ3.2), which threads through the primary channel, reaches the catalytic pocket with its hairpin loop (σ finger), and comes out from the RNA exit channel, almost completely blocking it (Figure 2). The rest of σ is wedged between the β and β′ clamps at the upstream side of the core enzyme, creating a wall that partially blocks the opening of the primary channel. Transition from core to holoenzyme is accompanied by partial closing of the β,β′ clamps by ~5 Å and movement of the flap domain (tip helix) induced by σ4 by ~12 Å (Vassylyev et al., 2002). The σ2, σ3, and σ4 domains are optimally positioned to contact the −10, extended −10, and −35 elements of the promoter DNA, respectively. In the crystal structures of Eco holoenzyme, consistent with previous biophysical studies (Mekler et al., 2002), σ region 1.1 is located in the downstream dsDNA binding region, blocking the access to DNA (Bae et al., 2013; Murakami, 2013). This location of σ1.1 explains why nonspecific transcription initiation by σ70-holoenzyme at promoterless DNA sequences is very low (Shorenstein and Losick, 1973). The σ-core interface is extensive with multiple cooperative contacts (Sharp et al., 1999; Gruber et al., 2001; Murakami and Darst, 2003), explaining the high stability of the σ-core association (KD ~0.3 nM; Maeda et al., 2000). However, most of these contacts appear to be relatively weak (Vassylyev et al., 2002; Borukhov and Nudler, 2003), which allows alternate σ factors to successfully compete for binding to core. The conserved regions 2.1 and 2.2 of s2 make the most stable contacts with the upstream β′ clamp helices—the major s docking site (Figure 2). σ4 interacts with the β-flap domain, with the C-terminus of σ contacting the β-flap tip. In the presence of specific activators, σ4 also interacts with σI-CTD. In the recent structure of σS-initation complex, σS regions from 1.2 to 4.2 display the same fold as σ70, including the linker 3.2 that inserts into the active site pocket (Liu et al., 2016). σS lacks the non-conserved domain present in σ70, which may explain its lower binding affinity to core (KD ~4 nM) (Maeda et al., 2000).

Figure 2.

Figure 2

Structural overview of RNAP holoenzyme and σ-DNA interactions. (A) The structure of Tth σA-holoenzyme is shown in molecular surface views with color coding as follows: αI, slate gray; αII, light gray; β, yellow; β′, cyan, σ, magenta, ω, dark cyan. Locations of conserved σ domains are indicated. The catalytic Mg2+ ion is shown as a small magenta sphere. The N-terminal domain of Eco σ70 carrying region 1.1 is modeled from the structure of Eco holoenzyme (PDB: 4YG2, Murakami, 2013) and shown as a red surface. Left panel, 2° channel view (as in Figure 1); right panel is obtained by rotation of the left panel view by 180° around the vertical axis, with the β subunit removed to reveal the location of σ3.2 finger region (colored light magenta) and σ4 occupying the RNA exit channel. (B) The structural and functional organization of σ. Top, a ribbon view of σA from Tth holoenzyme structure (PDB: 1IW7; Vassylyev et al., 2002) shown on the right panel in (A). Colored regions correspond to the evolutionarily conserved domains of σ as shown in the functional map of σ70 below. Bottom diagram, a linear representation of σ polypeptide with structural domains and conserved regions shown as numbered and color-coded boxes. Underneath is a diagram of DNA promoter regions showing interactions made by DNA-binding domains of σ, αCTD β′ zipper, and CRE-binding β lobe-2 elements.

Overview of the transcription cycle

Transcription process consists of three major stages: initiation, elongation, and termination. In bacteria, initiation occurs through five steps (Figure 3; reviewed in Murakami and Darst, 2003; Saecker et al., 2011).

Figure 3.

Figure 3

Schematic overview of the main steps in transcription initiation. RNAP is shown as a blue oval with the main channel cleft. αCTD is depicted as gray spheres connected to RNAP by flexible linkers (curved lines). σ domains are represented as colored ovals, except for σ3.2 which is drawn as a magenta curvy line connecting σ4 and σ3. The DNA t-strand and nt-strand are colored green and orange, respectively. The nascent RNA is shown as a curvy red line in a scrunched RPinit and in an EC with the DNA-hybridized section indicated. The scrunched part of the DNA bubble is shown as loops in RPinit scrunched. Two initiating NTPs are depicted as short red segments near the catalytic site in RPinit. The RNA exit channel and 2° channel are shown as funnels in dotted line. The catalytic Mg2+ ion is shown as small magenta sphere at the end of the 2° channel.

First, RNAP core enzyme, composed of five subunits (α2ββ′ω), binds one of several specificity factors, σ (such as σ70 for transcription of housekeeping genes in Escherichia coli) to form holoenzyme (Eσ70). Second, Eσ70 recognizes and binds promoter DNA, a pair of conserved hexameric sequences present at positions −35 and −10 relative to the transcription start site (TSS), where it forms a closed promoter complex (RPc). Sequences immediately upstream and downstream of the −10 element including “−15TG−14 extended −10” (Keilty and Rosenberg, 1987), “−15 enhancer” (or “−17/−18 zipper-binding”; Liu et al., 2004; Yuzenkova et al., 2011) and “−6GGGA−3 discriminator” (Feklistov et al., 2006; Haugen et al., 2006) regions, and A/T-rich regions upstream of the −35 element [“UP-element” at −45; −65 (Ross et al., 1993)], also contribute to specific recognition by the Eσ70 (reviewed in Decker and Hinton, 2013; Feklístov et al., 2014). Third, RPc undergoes a series of conformational changes (isomerization) through several transition states (such as intermediate complex, RPi), to form an open promoter complex (RPo). Isomerization results in unwinding of DNA duplex around the −10 region (typically, between nt −11 and +2- +4) and creates a 12–15 nt long transcription bubble, a hallmark of RPo. Fourth, in the presence of rNTPs, RPo converts to an initial transcribing complex (RPinit), forms the first phosphodiester bond between rNTPs positioned at +1 and +2 sites and then begins the RNA synthesis. During the synthesis beyond dinucleotide, RPinit undergoes “scrunching” whereby the downstream DNA (from +2 to +15) is pulled into the enzyme to be transcribed, resulting in bubble expansion (up to ~25 nt), while the upstream DNA-RNAP contacts remain intact (Kapanidis et al., 2006; Revyakin et al., 2006). At the same time, growth of nascent RNA beyond 6-mer is obstructed by the presence of σ3–4 linker in the RNA exit channel (Basu et al., 2014; Bae et al., 2015b). Biochemical data suggest that stress associated with DNA scrunching, and more importantly the steric clash between RNA 5′-end and σ3–4 (σ finger), together cause RNAP to repetitively synthesize and release short RNAs without leaving the promoter (abortive initiation; Sen et al., 1998; Murakami et al., 2002b; Kulbachinskiy and Mustaev, 2006; Samanta and Martin, 2013; Winkelman et al., 2016b). In the final step, the enzyme synthesizes an RNA of a critical length (typically 11–15 nt, of which ~9 nt are in the transcription bubble as RNA–DNA hybrid), removes the exit channel blockage, and escapes from promoter, entering the elongation stage of transcription. During this transition, RNAP undergoes global conformational change, which leads to the loss of RNAP-promoter DNA contacts, gradual σ dissociation, and formation of a highly stable and processive ternary elongation complex (EC) (Murakami and Darst, 2003).

Throughout elongation stage, the size of the transcription bubble in the EC remains constant at ~12 ± 1 nt, and the size of RNA/DNA hybrid is maintained at ~9–10 bp (Svetlov and Nudler, 2009; Kireeva et al., 2010). Elongating RNAP can transcribe DNA over long distances (>10,000 bp) without dissociation and release of RNA product. However, elongation does not proceed at a uniform rate; monotonous movement of RNAP can be interrupted by various roadblocks imposed by certain DNA sequences, DNA topology, lesions in transcribed DNA template, RNA secondary structures, DNA-binding proteins, DNA replication and repair machineries, ribosomes, other transcription complexes, RNAP-binding transcription factors (including σ70 that can be recruited back to EC upon encountering promoter-like sequences; Goldman et al., 2015; Sengupta et al., 2015), and small-molecule effectors (ppGpp) (Landick, 2006; Perdue and Roberts, 2011; Nudler, 2012; Imashimizu et al., 2014; Belogurov and Artsimovitch, 2015; Kamarthapu et al., 2016). Eventually, RNAP encounters a termination signal—a 20–35 nt-long G/C-rich RNA sequence of dyad symmetry that forms a hairpin structure immediately followed by a 7–9 nt-long stretch of Us (Yarnell and Roberts, 1999). During termination, RNAP releases the nascent transcript and dissociates from the DNA template, after which it can rebind a σ factor and start a new round of transcription. Under certain conditions, transcription termination can also be induced by termination factors ρ and Mfd (Roberts and Park, 2004; Kriner et al., 2016).

In this review, we discuss recent findings that elucidate molecular details of RNAP-DNA interactions during initiation the transcription cycle. Specifically, we will describe most current advances in the structural and biochemical studies of the molecular mechanisms underlying promoter recognition and RPo formation, activation of initiation, and promoter escape. Finally, we will review the mechanisms of action of known antibacterial drugs that specifically target RNAP.

Molecular details of transcription initiation and its activation

Structure of holoenzyme-promoter DNA complexes

Promoter recognition and binding: closed promoter complex (RPc)

Currently, there are no high resolution structure of the RPC, but a model of Taq RPc based on the existing structural, biochemical, biophysical, and genetic data has been proposed (Murakami et al., 2002a; Murakami and Darst, 2003). In the model, promoter dsDNA rests on the outer surface of the RNAP main channel, bound mostly by σ (Figure 3). RNAP contacts with −10, extended −10, and −35 elements of the promoter are established by σ2, σ3, and σ4 (regions 2.2–2.4, 3.0, and 4.2, respectively) through polar and van der Waals contacts. Additionally, residues of two αCTD helix–hairpin–helix motifs (Eco R265, N294, and K298) may contact A/T-rich sequences in the minor groove of the UP element at positions from −40 to −60 and up to −90 (Ross et al., 2001; Benoff et al., 2002). These weak but specific UP/αCTD interactions contribute to RPc formation (Haugen et al., 2008). However, with the exception of the −35 element/σ4 and the −12 bp of −10 element/σ2 contacts, other upstream dsDNA-RNAP interactions are mostly non-specific and weak, which makes RPc intrinsically unstable. Nonetheless, these interactions may provide initial promoter recognition and increase its occupancy by RNAP. They may also induce local distortion in DNA structure facilitating subsequent steps in transcription initiation: DNA melting, strand separation and template strand insertion into the active site cleft. For instance, the RNAP-bound DNA in the RPc appears to be bent or kinked at three places: around −25, to accommodate variable spacer length, at −35, induced by insertion of s4 helix-turn-helix motif into the major groove, and at −45, induced by αCTD-DNA minor groove interactions (Benoff et al., 2002). The DNA bending at −35 aids in the proper binding of upstream DNA by αCTD and upstream transcription activators. Additionally, recent structural and biochemical data on RPo (see below) implicate conserved residues of σ3 region 3.0 (Tth H278 and R274) and β′ zipper (Tth Y34 and R35, T36, and L37) in the recognition of non-canonical −17/−18 “Z-element” which contribute to promoter recognition and binding in RPc (Yuzenkova et al., 2011; Bae et al., 2015b). Notably, σ1.1 blocks the access to downstream (ds and ss) DNA in the main channel by binding with its negatively charged face (mimicking DNA) to the basic surface of the β lobe-2 and the downstream β′ clamp (Murakami, 2013). However, the opposite, positively charged face of σ1.1 is positioned to interact with the downstream DNA which may further stabilize RPc. Subsequent steps leading to displacement of σ1.1 by downstream DNA during transition to RPo are poorly understood, but are thought to involve β′-clamp opening triggered by upstream promoter DNA binding and initial DNA unwinding around −11 (see below).

Recently an alternative view on initial promoter recognition and RPc formation was proposed based on structural and biochemical data (Feklistov and Darst, 2011; Zhang et al., 2012; reviewed in Hook-Barnard and Hinton, 2007; Decker and Hinton, 2013; Feklistov, 2013). In this view, except for direct RNAP recruitment by transcription activators that provide sequence-specific DNA recognition, the upstream DNA-RNAP interactions (involving UP and −35 elements) play only an auxiliary role in RPc formation. Instead, initial promoter binding/recognition is accomplished through (i) indirect readout of DNA shape (a distinctive conformational patterns of stacked bases in dsDNA) by RNAP, and (ii) by direct readout of an indispensable −10 element by σ2-specific interaction with two flipped-out consensus nucleotides, −11(A) and −7(T), of nt-strand DNA (see below). These two views on the mechanism of promoter recognition are not mutually exclusive and could be eventually addressed when the structure of RPc becomes available.

Advances in structural studies of open promoter complex (RPo)

In the last 3 years several high resolution structures of Tth, Taq, and Eco RPo with different DNA scaffolds have been solved. These include upstream fork and downstream fork promoter DNA (Murakami et al., 2002a; Zhang et al., 2012, 2014; Basu et al., 2014), and complete transcription bubble promoter template with upstream and downstream dsDNA (Bae et al., 2015b; Zuo and Steitz, 2015; Liu et al., 2016). The structures of RPo correlate well and complement each other. Taken together, they reveal the positions of ds and ssDNA (from −36 to +12) in the complex and the key residues of RNAP that make critical interactions with DNA and RNA. Unlike RPc, in RPo both strands of downstream dsDNA up to +12 are fully enclosed inside the RNAP main channel (Figure 4). In RPo, RNAP makes tight contacts with DNA from −36 to −30 and −18 to +9, in agreement with DNA footprinting and crosslinking data (Ross and Gourse, 2009; Winkelman et al., 2015). The RNAP interactions with the upstream portion of ds DNA (from −36 to −12) are similar to that shown in RPc model, however, at −13/−12 the DNA bends sharply by ~90° toward the RNAP. At position −11, the t- and nt-strands separate, and enter different paths for ~13 downstream nucleotides until they form dsDNA at position +3, thus creating the “transcription bubble.”

Figure 4.

Figure 4

Detailed map of protein-nucleic acid interactions in RPo. Central panel shows the surface view of RPo structure of Taq σA-holoenzyme with full bubble promoter DNA (endpoints −36; +12) (PDB: 4XLN; Bae et al., 2015b). The color coding is the same as in Figure 2, except for β which is shown in brown. The displaced σ1.1 domain and the β′-NCD1 are not shown. Part of the β structure is removed (above of the thick gray line) to reveal the inside of the main channel and to show the interactions of σ and β′ with transcription bubble and ds DNA. DNA is shown as a worm in stick representation with t and nt strands colored dark green and yellow, respectively, with the main promoter elements indicated. EXT, extended −10. The small magenta ball indicates the position of catalytic Mg2+. (A–E) Zoomed-in detailed views of different sections of the central panel with key interacting residues and nucleotide positions indicated as sticks (A,B,D) or as surfaces (C,E). Interactions of (A) σ4 with the -35 DNA element; (B) β′ zipper and σ3 with −18/−17 and the extended −10 elements; (C) σ3 and σ2 with −10 element; (D) σ1.2 and β lobe-2 with DSR and CRE of the nt-strand DNA; (E) σ1.2–σ3.2 domains and β′ rudder, lid and switch-2 elements with the t-strand DNA spanning −11 to +1. Panel (E) highlights the interactions between basic patch residues of σ3 with the −11T at the upstream edge of transcription bubble, and the steric clash between the 4 nt-long RNA 5′ terminus and σ3.2 finger.

Upstream DNA (−35, −17/−18, and extended −10 elements)

In two RPo structures that contain a full bubble DNA (Bae et al., 2015b; Zuo and Steitz, 2015), contacts made at −35 region are the same as in isolated σ4 domain/−35 element (Figure 4A) (Campbell et al., 2002). As proposed for RPc, RPo structure demonstrates that duplex DNA upstream of the −10 element (−18 to −12) makes functionally important contacts with conserved residues of β′ zipper, σ3, and σ2 (Figure 4B), mostly through phosphate backbone of the nt-strand (Yuzenkova et al., 2011; Bae et al., 2015b; Feng et al., 2016). These contacts were not visible in the low resolution structures of RNAP with nucleic acids. The sequence specific recognition of extended −10 element (−15T:A, −14G:C) by conserved residues of σ2/σ3, E281 (Eco E458), R264 (R441), and V277 (V454), stabilizes RPo and can substitute for a poor or absent −35 element (Keilty and Rosenberg, 1987). Mutational analysis shows that all three residues are essential for promoter recognition (Daniels et al., 1990).

−10 element

The initial DNA melting starts at the A:T bp at position −11 (Chen and Helmann, 1997; Lim et al., 2001), when −11A flips out from the duplex DNA, and continues downstream to +1. Two groups of aromatic residues are involved in the initial stages of DNA melting (Figure 4C). First, W256 and W257 forming a chair-like structure interact with base-paired −12T at the upstream edge of the bubble replacing the flipped-out −11A. The second group of aromatic residues Y253, F242, and F248, together with two polar residues R246, E243 form a pocket that captures the flipped-out −11A base. Additionally, in the context of a true promoter, the −11T on the t-strand orphaned by the flipping of −11A, may be stabilized by stacking interaction with another highly conserved aromatic residue Y217 (Bae et al., 2015b). Neither the W256A nor Y217A substitution affected the promoter binding, but rather decreased the rate of RPc → RPo isomerization. Based on this, it is proposed that these residues maintain the ds-ss junction at the upstream edge of the bubble, preventing bubble collapse and RPo dissociation. In another structure of RPo with full bubble DNA and activator protein, R258 (R436) stacks on −12A of t-DNA, facilitating flipping of the t-strand −11 base (Feng et al., 2016). The second canonical nucleotide of the −10 element, −7T of nt-strand, is flipped out and captured in a pocket made of five σ2 and σ1.2 residues: E114, N206, L209, K249, and S251 (Eco E116, N383, R385, L386, S428; Figure 4C), all of which are functionally important (Zhang et al., 2012). Other nucleotides in −10 element make mostly nonspecific contacts with σ2.

Discriminator

The “discriminator” (DSR) region of nt-strand (consensus sequence −6G, −5G, −4G) interacts with eight σ1.2 residues, of which Tth L100 (Eco M102) and Tth H101 (Eco R103) provide the most functionally important contacts (Figure 4D). The purine-rich DSR contributes to the high stability of RPo, whereas pyrimidine-rich sequence in this region destabilizes it (Haugen et al., 2006). This is due to change in the interaction made by the key nucleotides of DSR (−5) with σ; when it is G, it forms and maintains an ordered, stacked conformation of the nt-strand, but when it is C, it flips and is captured by a pocket in σ2, resulting in unstacking and compaction of the downstream ssDNA. Importantly, the presence of C in the middle of DSR in rRNA promoters is also one of the determinants of the transcription start site (TSS) selection (Haugen et al., 2006; Winkelman et al., 2016b). The DSR–σ1.2 interaction is a major determinant of the susceptibility of rRNA and other promoters to negative regulation by ppGpp and DksA (Haugen et al., 2006).

CRE

Nucleotides at positions −3 to +2 on nt-strand constitute “core recognition element” (CRE) that interacts specifically with 10 residues of RNAP β-subunit. Six of these residues form a pocket that captures the flipped-out +2G of CRE at the downstream edge of the bubble, reminiscent of the capturing of flipped-out −11A by σ2. In the pocket, Tth βD326 (Eco D446) makes a hydrogen bond with +2G, which proved to be most critical (Zhang et al., 2012). Adjacent residue Tth βW171 (W183) unstacks the +1T away from the +2G, facilitating its placement into β pocket. In addition to stabilizing and maintaining transcription bubble in RPo, CRE-core interaction affects sequence-specific pausing, and determines TSS selection (Vvedenskaya et al., 2016; Winkelman et al., 2016b). Moreover, it is predicted that CRE-RNAP interactions will affect all stages of transcription where unwound transcription bubble is involved, e.g., slippage, abortive synthesis, promoter escape, factor dependent pausing, termination.

T-strand

A cluster of conserved, positively charged residues of σ2.4 and σ3.0 (Taq R288, and R291, R220) pulls the DNA t-strand from −13 to −10, bending it by 90° through electrostatic interaction with the phosphate backbone, into a groove formed by σ3 linker, β′ lid, and the β′ rudder (Figure 4E; Bae et al., 2015b; Zuo and Steitz, 2015). The t-strand DNA (−9 to −5) is then placed into the main channel between the active site wall, mostly of β, and s3.2 hairpin loop (σ finger), which participates in juxtaposing DNA +1 position to the catalytic center (Figure 4E). Simultaneously, the dsDNA downstream of +3 to +12 is brought inside the downstream DNA binding clamp between the β′ jaw, β lobe-2 and the downstream β′ clamp. The β′ switch-2, a small flexible loop residing in the upstream β′ clamp in the middle of the main channel cavity, controls the binding of the downstream part of the unwound DNA t-strand in the active site cleft. β′ switch-2 functions as a hinge mediating opening and closing of the β′ clamp, and plays a critical role in downstream propagation of transcription bubble during formation of RPo (Mukhopadhyay et al., 2008; Belogurov et al., 2009; Bae et al., 2015b).

Role of σ3.2 finger in RPinit

Recent structural studies showed that during initial transcript synthesis, σ3.2 loop physically occupies the path of nascent RNA and sterically blocks its extension beyond 4~5 nucleotides (Zhang et al., 2012; Basu et al., 2014; Bae et al., 2015b; Zuo and Steitz, 2015). Consistent with its position in the structure of RPo and RPinit, biochemical data show that σ3.2 finger positively affects the binding of the first two initaiting NTPs, abortive RNA synthesis, and promoter escape (Murakami et al., 2002b; Kulbachinskiy and Mustaev, 2006). More recent studies revealed that σ3.2 contributes to promoter opening (Morichaud et al., 2016), suppresses σ-dependent promoter proximal pausing, and accelerates σ dissociation during transition from initiation to elongation (Pupov et al., 2014).

Transcription start site selection (role of DNA scrunching in RPo)

Transcription typically initiates 7 or 8 bp downstream from the −10 element, with a strong bias for purine (R) over pyrimidine (Y) as the initiating nucleotide (+1 position) (Shultzaberger et al., 2007). To identify the determinants for TSS selection, Nickels and coworkers combined a high throughput sequencing (MASTER, “massively systematic transcript end readout”) with multiplexed site-specific RNAP-DNA crosslinking and X-ray structural analyses, to dissect and characterize the role of sequence variation within −6 to +4 positions of the promoter on TSS selection (Winkelman et al., 2016b). The studies identified DSR and CRE as sequence elements that significantly influence TSS selection. G-rich DSR (GGG) and +2G CRE shortens the distance between TSS and −10 element (6-/7-nt from the edge of −10 element), whereas pyrimidine-rich DSR (CCC) and lack of CRE shifts TSS further downstream (8-/9-nt from the edge of −10 element). Disrupting the DSR-σ1.2 and/or CRE-β pocket interactions results in downstream shift of TSS. The changes in TSS correlate with the corresponding shift in the downstream edge of the transcription bubble (in + or − direction), while the upstream edge of the transcription bubble (−10 element) remains constant, demonstrating TSS selection involves transcription-bubble expansion (“scrunching”) and transcription-bubble contraction (“anti-scrunching”; Vvedenskaya et al., 2015; Winkelman et al., 2016b).

Importantly, the unique features of ribosomal promoter sequence (short suboptimal 16 bp spacer, absence of extended −10, and the lack of interactions of DSR/σ1.2, and CRE/β pocket) lead to RPo pre-scrunching and downstream shift of TSS to an unusual position 9 nt from the −10 element. These features reduce abortive synthesis and facilitate promoter escape during initiation, contributing to the high transcriptional activity of rRNA promoters (Winkelman et al., 2016a). At the same time, they destabilize RPo and increase its sensitivity to initiating NTP concentrations, providing a mechanism for rapid down-regulation during starvation.

Besides the TSS region sequences, the negative DNA supercoiling that increases the size of the transcription bubble in RPo also causes downstream shift in the TSS position (Vvedenskaya et al., 2015). These results are consistent with biophysical data correlating bubble expansion with TSS selection (Robb et al., 2013).

Initiation of RNA synthesis

Structures of RPinit were obtained by stabilizing the crystal structures of RPo with RNA oligos complementary to t-strand in the bubble from positions −4 to +1. However, these structures do not reflect the natural state of nascent transcript and DNA during transcription initiation. Recently, more functionally relevant structural data were obtained for RPinit by soaking the crystals of RPo with two initiating substrates, ATP and a non-hydrolyzable anolog of CTP, CMPcPP, occupying i and i+1 sites, respectively. The structure revealed the location of initiating substrate, ATP, in the catalytic center. However, CMPcPP does not occupy the catalytically reactive site since the position of its α-phosphate and the second Mg2+ ion coordinated by its β- and γ-phosphates are too far for catalysis. Also, the trigger helix is partly disordered and does not interact with phosphates of the substrate. Therefore, it is proposed that this structure captures RPinit in a transient state where, i+1 nucleotide is in pre-catalytic conformation (Basu et al., 2014; Zhang et al., 2014; Zuo and Steitz, 2015). De novo synthesis of 6-nt long transcript in crystallo generated a structure of RPinit with RNA-DNA hybrid and the scrunched downstream dsDNA. In the structure, σ3.2 finger is displaced from its position near the active site by the RNA 5′ end, signaling the beginning of σ release from RNAP (Basu et al., 2014).

During scrunching, the pulled-in portions of t- and nt-strands must bulge out of the transcription bubble. Because the X-ray structures of the scrunched ssDNA in RPinit are disordered, their paths have been recently assessed by site-specific DNA-protein crosslinking (Winkelman et al., 2015), exploiting the unusual stability of RPinit formed at ribosomal rrnBP1 promoter (Borukhov et al., 1993). In RPinit containing 5-mer RNA, the nt-strand bulge is extruded through the space between lobe 1 and 2 of β clamp into solvent, whereas the t-strand bulge remains inside the RNAP main channel restricted by the β flap, β lid, β′ clamp, and σ3.2 finger. Mapping results indicate that the t-strand bulge moves toward RNA exit channel, but its exact position is unclear. Extension of RNA beyond 5–6 nt will lead to further bulge expansion resulting in stress build-up, which can be relieved by displacement of σ3.2 finger and/or by opening of the β flap and β′ clamp domains. Further stress accumulation may cause the t-strand bulge to extrude outside either through expansion of the RNA exit channel or through the space opened up between β lobe 1 and σ3. Eventually, the growing 5′ end of nascent RNA will occupy the exit channel displacing σ3 and 4, commencing promoter escape. Another way to relieve the stress caused by t-strand bulge expansion is to reverse the scrunching by releasing the abortive RNA products through the 2°-channel and repeat initiation (Kapanidis et al., 2006; Revyakin et al., 2006).

Activation of transcription initiation

Many bacterial promoters contain suboptimal sequences that require binding of specific factors for efficient transcription initiation. Various classes of activators act by facilitating RNAP recruitment to promoters and by accelerating isomerization steps in initiation pathway: RPc → RPi → RPo → RPinit → promoter escape (reviewed in Roy et al., 1998; Lee et al., 2012; Decker and Hinton, 2013). Below, we present two examples of transcription activation systems that have been recently characterized with structural, genetic, and biochemical studies.

Transcription activation by class II initiation factors: CAP/TAP

Two well-characterized classes of transcriptional activators (class I and II) act through simple RNAP recruitment to promoters with missing or inefficient core promoter elements. Class I activators, exemplified by E. coli CAP (catabolite activator protein) binding at the −61.5 DNA site upstream of the lac promoter, stimulate RPc formation through direct interactions with the RNAP αCTD. Class II activators, such as E. coli CAP binding at the −41.5 site overlapping the −35 element of gal promoter, facilitate formation of RPc and its isomerization into transcriptionally active RPo through multiple contacts (activation regions AR1–AR3) with RNAP αNTD, αCTD, and σ4 domains (Lawson et al., 2004). A structural model of an E. coli class I transcription activation complex of CAP-RPo on a modified lac promoter based on a low resolution electron microscopy data has been generated (Lawson et al., 2004; Hudson et al., 2009) providing information on CAP/DNA, αCTD-DNA, and αCTD-σ4 interactions.

Recently, a 4.4 Å-resolution crystal structure of class II transcription activation complex was reported. It shows Tth activator protein TAP, a homolog of E. coli CAP, in complex with Tth RPo assembled on a TAP-dependent Tth crtB promoter, with a full transcription bubble and a 4 nt-RNA primer (Feng et al., 2016). In the structure, Tth TAP homodimer is bound to DNA at position −41.5 from transcription start site. As expected based on their sequence homology, the structures of Tth TAP-DNA and Eco CAP-DNA are very similar. The structure of RPo is mostly unchanged in TAP-RPo, except that DNA upstream of −35 is slightly distorted by TAP, resulting in reduced interaction between −35 region and σ4. Not surprisingly, biochemical data indicate that specificity of −35 recognition by σ4 does not play a major role in Class II CAP-mediated activation (Rhodius et al., 1997). Yet, intriguingly, mutations of the two σ4 residues (R584, E585) contacting bases at −32 and −33 strongly inhibited RPo formation (Feng et al., 2016). Apparently, the few remaining specific interactions between σ4 and −35 still play an important role in TAP mediated activation.

Role of αCTD in activation

In TAP-RPo structure, the distal subunit of TAP homodimer interacts with one αCTD through an interface that includes ~8 pairs of partnering residues. This interaction (mediated by activation region AR4, a unique feature of TAP) is essential for RPc formation, as demonstrated by the loss of promoter binding following substitutions of AR4/αCTD interface residues. In addition, unlike Eco CAP-RPo, αCTD in TAP-RPo does not interact with DNA. DNA footprinting data show that Tth αCTD does not contribute to DNA binding irrespective of TAP or promoter sequences (Feng et al., 2016), indicating that αCTD is used by TAP only as an RNAP-tether. Indeed, CAP and TAP use different regions to contact αCTD (AR1 and AR4, respectively) that may play a different role in activation. Whereas Eco CAP-AR1/αCTD interaction serves to recruit RNAP to the promoter by DNA-bound CAP, TAP-AR4/αCTD interaction facilitates the association of free RNAP and TAP prior to promoter DNA binding. Because the RNAP-TAP binding constant (6 μM) is comparable to the intracellular RNAP concentration [>5 μM (Patrick et al., 2015)], it is proposed that in addition to classic recruitment pathway, TAP may activate transcription via a pre-recruitment pathway, similar to the mechanism of eukaryotic transcription activation.

The role of TAP-AR2 and -AR3 in activation

TAP-AR2 interacts with β flap domain while TAP-AR3 interacts with σ4 and the β-flap tip helix. Most of these interactions are mediated through polar contacts and salt bridges, and are conserved between Eco CAP and Tth TAP. Mutation of residues in the AR2/β-flap, AR3/β-flap tip, and AR3/σ4 interfaces lead to defects in transcription activation by TAP. Kinetic analysis indicate that similar to CAP (Niu et al., 1996; Rhodius et al., 1997; Rhodius and Busby, 2000), interactions of TAP AR2- and AR3- with RNAP accelerate the transition of RPc to RPo but do not play a significant role in the initial DNA binding (RPc formation).

From the observation that the RPo structure does not change upon interaction with TAP, it is inferred that the mechanism of TAP/CAP Class II activation entails sequential stabilization of intermediate complexes (between RPc and RPo) through simple contacts between ARs and RNAP without inducing any conformational perturbations in RNAP. It should be noted, however, that the reported TAP-RPo structure presents the complex in the final activated state, whereas the path to this state is poorly understood. An alternative to the “activation by adhesion” mechanism can be envisaged which entails allosteric/conformationl changes in the intermediate initiation complexes.

Transcription activation by RPo stabilization: CarD

Unlike RNAP of the model organism Eco, RNAPs of many bacteria form intrinsically unstable RPo even at consensus promoters, and require additional factors to stabilize RPo. One such factor is CarD, a global regulator which is an essential factor in Mtb. CarD is widely distributed in at least ten bacterial phyla, including Firmicutes, Cyanobacteria, Actinobacteria, and Deinococcus-Thermus (Bae et al., 2015a), but is absent in γ-Proteobacteria such as Eco. The structure and function of Mtb and Tth CarD have been characterized (Stallings et al., 2009; Gulten and Sacchettini, 2013; Srivastava et al., 2013), and the molecular mechanism of its action was recently proposed based on the 3-D structure of Tth CarD in complex with RPo assembled on consensus promoter DNA with full transcription bubble (Bae et al., 2015a).

CarD consists of N-terminal, RNAP-interacting domain (CarD-RID) and α helical C-terminal domain (CarD-CTD). In CarD-RPo structure, CarD-RID binds RNAP β lobe-1 domain, orienting CarD-CTD toward the upstream ds/ss junction of the transcription bubble near the −10 element. One of the α-helices of CarD-CTD inserts a conserved W86 into the DNA minor groove near positions −12/−13, and acts as a wedge to maintain the distorted conformation of the minor groove immediately upstream of the fork junction. This action is proposed to prevent the reannealing of t- and nt-strands and collapse of transcription bubble, thus stabilizing the RPo. The proposed mechanism of CarD action is strongly supported by the experimental evidence. First, CarD did not affect the conformation of RPo in the structure or alter the size of the transcription bubble during RPo formation on native promoters. Second, kinetic data showed that CarD increased the resistance of RPo to competitor challenge in in vitro assays on native promoters, although it had no effect on RPo assembled on artificial bubble templates (Davis et al., 2015). Finally, mutational analysis indicated that specific interaction between W86 and −12T of nt-strand plays a critical role in RPo stabilization (Bae et al., 2015a). Thus, transcription activation by CarD entails stabilizing the RPo, and prolonging its lifetime sufficient for successful initiation of RNA synthesis.

Analysis of CarD chromosomal distribution using ChipSeq revealed that CarD is associated with RNAP predominantly at promoter regions, co-localizing with σA (Stallings et al., 2009; Srivastava et al., 2013), suggesting that CarD dissociates during early stages of elongation. It's unclear what causes its dissociation. Since the CarD-RID is homologous to the NTD of Mfd, transcription coupled repair factor, which also binds to the β lobe-1, it is possible that CarD is displaced from elongation complex by Mfd. Also, because CarD stabilizes the RPo, it would be expected to negatively affect the rate of promoter escape. Additional biochemical experiments would be needed to address this hypothesis.

Transcription inhibitors that target RNAP

Because bacterial RNAP performs essential functions in the cell, and because it differs sufficiently from eukaryotic RNAPs, it is an attractive target for antibiotics (for comprehensive review on the subject, see Ma et al., 2016). Currently, known drugs targeting RNAP can be divided into three groups based on their modes of action (Table 1): (i) those that disrupt RNAP interactions with DNA, RNA or NTPs; (ii) those that interfere with the movement of RNAP mobile elements during nucleotide addition cycle (NAC); and (iii) those that disrupt RNAP interactions with the housekeeping initiation factor, σ70. Although many of these drugs were discovered decades ago, and have been extensively characterized biochemically and genetically since then, it is only with the recent avalanche of structural data obtained for bacterial RNAP in complex many inhibitors that their mechanism of action began to be truly revealed at the molecular level (Murakami, 2015). Below, we summarize briefly the current understanding of how these drugs interact with RNAP from a structural point of view.

Table 1.

Small molecule inhibitors that target RNAP.

Classification Name Source Binding site Comment References
Inhibitors that disrupt Rifamycins Amycolatopsis mediterranei β subunit active site cleft High resistance spectrum Campbell et al., 2001; Molodtsov et al., 2013
RNAP—DNA/RNA/NTPs interactions Sorangicin Sorangium cellulosum Campbell et al., 2005
GE23077 Actinomadura sp i/i+1 NTP binding site Low resistance spectrum but poor membrane permeability Zhang et al., 2014
GE-Rif semi-synthetic composite of Rif- and GE-binding sites Zhang et al., 2014
Microcin E. coli AY25 2° channel (based on modeling) High resistance spectrum, active against Gram(−) only Adelman et al., 2004; Mukhopadhyay et al., 2004
Myxopyronins Myxococcus fulvus β′ Switch-2 broad-spectrum antibacterial (Gram+ and Gram−) Mukhopadhyay et al., 2008; Belogurov et al., 2009; Srivastava et al., 2011
Corallopyronin Corallococcus coralloides
Ripostatin Sorangium cellulosum
Squaramides synthetic Buurman et al., 2012; Molodtsov et al., 2015
Fidaxomicin Dactylosporangium aurantiacum β′ Switch-2 (σ70/S R3.2)* active against Gram (+) Artsimovitch et al., 2012
Lipiarmycin Actinoplanes deccanensis Tupin et al., 2010; Morichaud et al., 2016
Inhibitors that constrain the mobile elements of RNAP active center Streptolydigin Streptomyces lydicus β′ BH, β′ TL, β fork loop-2 (downstream DNA)* High resistance spectrum Temiakov et al., 2005; Tuske et al., 2005; Vassylyev et al., 2007
Salinamide marine and soil Streptomyces spp β′ BH hinge region (near 2°-channel), β′ F-loop, β-link, (β′ TL)* Poor membrane permeability Degen et al., 2014
CBR compounds chemical compound library β element between fork loop 2 and β DII, β′ F-loop, β′ BH hinge region Low resistance spectrum but tested only in TolC strain; cytotoxic Artsimovitch et al., 2003, 2011; Malinen et al., 2012, 2014; Yuzenkova et al., 2013; Bae et al., 2015c; Feng et al., 2015
Tagetitoxin Pseudomonas syringae pv. tagetis 2°-channel; β′ catalytic loop and adjacent residues, β′ clip; β-link, β active site loop, Mg2+(II) (β′ TL)* Low membrane permeability Artsimovitch et al., 2011; Malinen et al., 2012; Yuzenkova et al., 2013
Inhibitors that disrupt RNAP-σ70 interactions GKL003 chemical compound library β′ clamp helices (CH) High affinity (Ki ~6 nM) but low solubility and permeability Ma et al., 2013; Yang et al., 2015a
DSHS00507 drug-like compound library β′ clamp helices (CH) Effective against Gram-positive bacteria
SB series compound library undefined IC50: 2~15 μM but low target specificity André et al., 2004, 2006
*

Indicates possible auxiliary binding site.

The first group comprises inhibitors that bind in the primary channel, the secondary channel, or to the β′ switch-2 region of RNAP. Rifamycins (RIF) and sorangicin bind in the primary channel near the active site, directly contacting β subunit, and sterically block the path of growing RNA beyond 2-3 nucleotides in length, effectively locking the abortive initiation complex at the promoter (Campbell et al., 2001, 2005; Molodtsov et al., 2013). GE23077 binds to the i and i+1 sites of the active center, immediately adjacent to the catalytic Mg2+ ion, and sterically occludes natural substrates from binding to these sites, inhibiting RNAP from initiating transcription de novo (Zhang et al., 2014). Using the structural information and modeling, a bipartite drug that binds to adjoining (but not overlapping) sites near the active center of RNAP was created by covalently linking GE and rifamycin SV (RIF derivative). The resulting compound, RifaGE-3, was active against both RifR and GER RNAPs (Zhang et al., 2014), suggesting that bipartite drugs could represent a new class of antibiotics to combat pathogenic bacteria that are increasingly drug-resistant. However, their large size and complexity may cause reduced permeability and increased cytotoxicity.

Microcin binds in the 2° channel and competitively prevents NTP uptake or binding, thereby inhibiting abortive initiation and elongation (Adelman et al., 2004; Mukhopadhyay et al., 2004). Compounds like myxopyronins, corallopyronin (Mukhopadhyay et al., 2008), ripostatin (Mukhopadhyay et al., 2008; Belogurov et al., 2009), and squaramides (Buurman et al., 2012; Molodtsov et al., 2015) bind to RNAP β′ switch-2 region that controls the hinged, swinging motion of β′ clamp, which in turn is responsible for the opening and closing of the primary channel (Srivastava et al., 2011). Binding of these compounds prevents the β′ clamp from opening, stabilizes the β′ clamp/switch regions in a partly closed/fully closed conformation, and prevents template DNA from reaching the active site. In particular, squaramide, in its co-crystal structure with RNAP, is shown to displace β′ switch-2 into the DNA binding main channel of RNAP (Molodtsov et al., 2015), which would interfere with proper placement of the melted template DNA (Bae et al., 2015b). Fidaxomicin and lipiarmycin (Tupin et al., 2010; Artsimovitch et al., 2012; Morichaud et al., 2016) are structurally closely related natural compounds that also bind to the β′ switch-2 region and prevent t-strand DNA from accessing the RNAP active-site cleft. Interestingly, the sensitivity of RNAP to lipiarmycin is aggravated in the presence of specific mutations in σ70 that are known to destabilize RPo (Morichaud et al., 2016). This result supports the assertion that lipiarmycin, and likely fidoxymicin, competes with t- strand DNA for the same binding site on RNAP β′ switch-2 region during RPo formation, and effectively inhibits promoter melting and RPo formation.

The second group comprises inhibitors that interact with, or bind near the catalytically important mobile elements of RNAP, β′ BH, β′ TL, β-link, and F-loop. These mobile elements are located in the immediate vicinity of the active site of RNAP, and are proposed to undergo conformational changes in concert with NAC (Malinen et al., 2012). Notably, the β′ TL alternates between “open” (unfolded) and “closed” (folded) states, while the adjacent β′ BH alternates between bent and straight conformations (Wang et al., 2006; Jovanovic et al., 2011). These structural changes are thought to accompany each NAC during transcription. In the “closed” conformation, β′ TL forms a three-helix bundle with β′ BH, and is directly contacted by the residues of F-loop and the β-link, which leads to further stabilization of the folded conformation of the β′ TL. NTP loading and catalysis occur in this state. In the “open” conformation, the three-helix bundle collapses: β′ BH bends toward RNA–DNA hybrid; β′ TL becomes unfolded. This state presumably permits RNA and DNA translocation following catalysis. Streptolydigin (Temiakov et al., 2005; Tuske et al., 2005; Vassylyev et al., 2007), salinamide (Degen et al., 2014), CBR (Artsimovitch et al., 2003, 2011; Malinen et al., 2012, 2014; Yuzenkova et al., 2013; Bae et al., 2015c; Feng et al., 2015), and, most likely targetitoxin (Artsimovitch et al., 2011; Malinen et al., 2012; Yuzenkova et al., 2013), are all inhibitors that bind RNAP and interact intimately with non-overlapping residues of β′ BH, β′ TL, β′ F-loop, and/or β-link in the active site milieu. Extensive structural and biochemical studies support the mechanistic model that these inhibitors stabilize an intermediate complex formed during NAC by immobilizing one or more mobile elements in a fixed conformation, thereby halting the iterative catalytic process. Binding sites of salinamide and CBR on Eco RNAP identified from analysis of X-ray co-crystal structures are consistent with their genetically-mapped binding sites. Interestingly, it was reported that two CBRR mutations, P750 → L in β′ F-loop and F773 → V in β′ BH N-terminus, also conferred CBR dependence for cell growth (Bae et al., 2015c). One possible explanation for this observation is that the mutations made these mobile elements too flexible to support NAC, and that binding of CBR compensated for this defect. This interpretation would be consistent with the proposed mechanism of action of CBR.

The third group of inhibitors include compounds of GKL-, DSHS-, and SB-series, all derived from chemical compound libraries, that are predicted to directly inhibit RNAP-σ70 interaction. The SB-series compounds were discovered by screening the library using ELISA-based assay, and while they inhibited RNAP-σ70 association with IC50 ranging from 2 to 15 μM, many showed nonspecific binding to unrelated targets in vivo (André et al., 2004, 2006). GKL- and DSHS-series were screened in silico based on the strategy of structure-based drug design, and subsequently tested in vitro for validation (Ma et al., 2013; Yang et al., 2015a). As predicted by pharmacophore modeling, select compounds of GKL- and DSHS-series were shown to compete with σ70 for binding to RNAP core to form holoenzyme. More analysis and characterization is required to determine if these compounds can be further developed as potential antibacterial drugs. In theory, it should be possible to screen for compounds that inhibit σ dissociation from RPo using the same pharmacophore model (Ma et al., 2013), or one based on the RPo complex structure. An attractive target interface for such an inhibitor would be the RNA exit channel, where blocking of σ3.2 release would cause essentially the same inhibitory effect as RIF.

A survey of currently available RNAP-specific inhibitors reveals that for many lead compounds, the predicted in vivo effectiveness is often low due to their poor permeability, cytotoxicity, and broad resistance spectrum. Therefore, future drug designs will need to include strategies for incorporating effective delivery mechanisms, such as nanoparticles or functional conjugates that can be cleaved/unloaded inside the cell. Design for new drugs should also aim to improve solubility and reduce nonspecific, aggregate-forming properties of drugs associated with cytotoxicity. The construction of bipartite molecules, in principle, offers a highly promising approach to achieve increased potency and low resistance spectrum. It remains to be seen if, with the right combination of linked inhibitors and modifications, an effective bipartite drug can be constructed that is permeable with negligible toxicity. Finally, to design inhibitors of RNAP with narrow resistance spectrum, it is instructive to note that Sorangicin, which resembles RIF and binds to the same site on RNAP, exhibits a narrower resistance spectrum than RIF. This is attributed to its presumed greater conformational flexibility, enabling it to accommodate mutations in the RIF-binding pocket (Campbell et al., 2005). This suggests that a built-in structural flexibility of the compound may be an important factor in smart drug design.

Concluding remarks

The last 15 years saw a remarkable progress in our understanding of the structure-function relationship of bacterial RNAP thanks to the advances in structural studies of this enzyme. It is hoped that in the near future, structural studies will continue to reveal fine details of transcription, especially of the events during formation of RPc, scrunching of RPinit and termination processes. Additionally, an exciting new direction in RNAP research is emerging with the advent of high throughput sequencing and screening techniques, which will help to shed new light on the function of RNAP in the context of true physiological environment.

Author contributions

JL and SB equally contributed to the preparation and writing of the manuscript.

Funding

Research in SB lab is supported by the Department of Cell Biology and the Graduate School of Biomedical Studies at Rowan University.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

Authors are grateful to our colleagues R. Gourse, E. Nudler, A. Kulbachinskiy, and M. Cashel for helpful discussions and advices. We apologize to those researchers whose work has not been cited due to space limitations.

References

  1. Adelman K., Yuzenkova J., La Porta A., Zenkin N., Lee J., Lis J. T., et al. (2004). Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25. Mol. Cell 14, 753–762. 10.1016/j.molcel.2004.05.017 [DOI] [PubMed] [Google Scholar]
  2. André E., Bastide L., Michaux-Charachon S., Gouby A., Villain-Guillot P., Latouche J., et al. (2006). Novel synthetic molecules targeting the bacterial RNA polymerase assembly. J. Antimicrob. Chemother. 57, 245–251. 10.1093/jac/dki426 [DOI] [PubMed] [Google Scholar]
  3. André E., Bastide L., Villain-Guillot P., Latouche J., Rouby J., Leonetti J. P. (2004). A multiwell assay to isolate compounds inhibiting the assembly of the prokaryotic RNA polymerase. Assay Drug Dev. Technol. 2, 629–635. 10.1089/adt.2004.2.629 [DOI] [PubMed] [Google Scholar]
  4. Artsimovitch I., Chu C., Lynch A. S., Landick R. (2003). A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science 302, 650–654. 10.1126/science.1087526 [DOI] [PubMed] [Google Scholar]
  5. Artsimovitch I., Seddon J., Sears P. (2012). Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis. Clin. Infect. Dis. 55(Suppl. 2), S127–S131. 10.1093/cid/cis358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Artsimovitch I., Svetlov V., Nemetski S. M., Epshtein V., Cardozo T., Nudler E. (2011). Tagetitoxin inhibits RNA polymerase through trapping of the trigger loop. J. Biol. Chem. 286, 40395–40400. 10.1074/jbc.M111.300889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bae B., Chen J., Davis E., Leon K., Darst S. A., Campbell E. A. (2015a). CarD uses a minor groove wedge mechanism to stabilize the RNA polymerase open promoter complex. Elife 4:e08505. 10.7554/eLife.08505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bae B., Davis E., Brown D., Campbell E. A., Wigneshweraraj S., Darst S. A. (2013). Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of sigma70 domain 1.1. Proc. Natl. Acad. Sci. U.S.A. 110, 19772–19777. 10.1073/pnas.1314576110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bae B., Feklistov A., Lass-Napiorkowska A., Landick R., Darst S. A. (2015b). Structure of a bacterial RNA polymerase holoenzyme open promoter complex. Elife 4:e08504. 10.7554/eLife.08504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bae B., Nayak D., Ray A., Mustaev A., Landick R., Darst S. A. (2015c). CBR antimicrobials inhibit RNA polymerase via at least two bridge-helix cap-mediated effects on nucleotide addition. Proc. Natl. Acad. Sci. U.S.A. 112, E4178–E4187. 10.1073/pnas.1502368112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Basu R. S., Warner B. A., Molodtsov V., Pupov D., Esyunina D., Fernández-Tornero C., et al. (2014). Structural basis of transcription initiation by bacterial RNA polymerase holoenzyme. J. Biol. Chem. 289, 24549–24559. 10.1074/jbc.M114.584037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Belogurov G. A., Artsimovitch I. (2015). Regulation of Transcript Elongation. Annu. Rev. Microbiol. 69, 49–69. 10.1146/annurev-micro-091014-104047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Belogurov G. A., Vassylyeva M. N., Sevostyanova A., Appleman J. R., Xiang A. X., Lira R., et al. (2009). Transcription inactivation through local refolding of the RNA polymerase structure. Nature 457, 332–335. 10.1038/nature07510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Benoff B., Yang H., Lawson C. L., Parkinson G., Liu J., Blatter E., et al. (2002). Structural basis of transcription activation: the CAP-alpha CTD-DNA complex. Science 297, 1562–1566. 10.1126/science.1076376 [DOI] [PubMed] [Google Scholar]
  15. Borukhov S., Nudler E. (2003). RNA polymerase holoenzyme: structure, function and biological implications. Curr. Opin. Microbiol. 6, 93–100. 10.1016/S1369-5274(03)00036-5 [DOI] [PubMed] [Google Scholar]
  16. Borukhov S., Nudler E. (2008). RNA polymerase: the vehicle of transcription. Trends Microbiol. 16, 126–134. 10.1016/j.tim.2007.12.006 [DOI] [PubMed] [Google Scholar]
  17. Borukhov S., Sagitov V., Josaitis C. A., Gourse R. L., Goldfarb A. (1993). Two modes of transcription initiation in vitro at the rrnB P1 promoter of Escherichia coli. J. Biol. Chem. 268, 23477–23482. [PubMed] [Google Scholar]
  18. Buurman E. T., Foulk M. A., Gao N., Laganas V. A., McKinney D. C., Moustakas D. T., et al. (2012). Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae. J. Bacteriol. 194, 5504–5512. 10.1128/JB.01103-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Campbell E. A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., et al. (2001). Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104, 901–912. 10.1016/S0092-8674(01)00286-0 [DOI] [PubMed] [Google Scholar]
  20. Campbell E. A., Muzzin O., Chlenov M., Sun J. L., Olson C. A., Weinman O., et al. (2002). Structure of the bacterial RNA polymerase promoter specificity sigma subunit. Mol. Cell 9, 527–539. 10.1016/S1097-2765(02)00470-7 [DOI] [PubMed] [Google Scholar]
  21. Campbell E. A., Pavlova O., Zenkin N., Leon F., Irschik H., Jansen R., et al. (2005). Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J. 24, 674–682. 10.1038/sj.emboj.7600499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Chen Y. F., Helmann J. D. (1997). DNA-melting at the Bacillus subtilis flagellin promoter nucleates near -10 and expands unidirectionally. J. Mol. Biol. 267, 47–59. 10.1006/jmbi.1996.0853 [DOI] [PubMed] [Google Scholar]
  23. Daniels D., Zuber P., Losick R. (1990). Two amino acids in an RNA polymerase sigma factor involved in the recognition of adjacent base pairs in the -10 region of a cognate promoter. Proc. Natl. Acad. Sci. U.S.A. 87, 8075–8079. 10.1073/pnas.87.20.8075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Davis E., Chen J., Leon K., Darst S. A., Campbell E. A. (2015). Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD. Nucleic Acids Res. 43, 433–445. 10.1093/nar/gku1231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Decker K. B., Hinton D. M. (2013). Transcription regulation at the core: similarities among bacterial, archaeal, and eukaryotic RNA polymerases. Annu. Rev. Microbiol. 67, 113–139. 10.1146/annurev-micro-092412-155756 [DOI] [PubMed] [Google Scholar]
  26. Degen D., Feng Y., Zhang Y., Ebright K. Y., Ebright Y. W., Gigliotti M., et al. (2014). Transcription inhibition by the depsipeptide antibiotic salinamide A. Elife 3:e02451. 10.7554/eLife.02451 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Feklistov A. (2013). RNA polymerase: in search of promoters. Ann. N.Y. Acad. Sci. 1293, 25–32. 10.1111/nyas.12197 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Feklistov A., Barinova N., Sevostyanova A., Heyduk E., Bass I., Vvedenskaya I., et al. (2006). A basal promoter element recognized by free RNA polymerase sigma subunit determines promoter recognition by RNA polymerase holoenzyme. Mol. Cell 23, 97–107. 10.1016/j.molcel.2006.06.010 [DOI] [PubMed] [Google Scholar]
  29. Feklistov A., Darst S. A. (2011). Structural basis for promoter-10 element recognition by the bacterial RNA polymerase sigma subunit. Cell 147, 1257–1269. 10.1016/j.cell.2011.10.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Feklístov A., Sharon B. D., Darst S. A., Gross C. A. (2014). Bacterial sigma factors: a historical, structural, and genomic perspective. Annu. Rev. Microbiol. 68, 357–376. 10.1146/annurev-micro-092412-155737 [DOI] [PubMed] [Google Scholar]
  31. Feng Y., Degen D., Wang X., Gigliotti M., Liu S., Zhang Y., et al. (2015). tructural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure 23, 1470–1481. 10.1016/j.str.2015.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Feng Y., Zhang Y., Ebright R. H. (2016). Structural basis of transcription activation. Science 352, 1330–1333. 10.1126/science.aaf4417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Goldman S. R., Nair N. U., Wells C. D., Nickels B. E., Hochschild A. (2015). The primary sigma factor in Escherichia coli can access the transcription elongation complex from solution in vivo. Elife 4:e10514. 10.7554/eLife.10514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Gruber T. M., Gross C. A. (2003). Multiple sigma subunits and the partitioning of bacterial transcription space. Annu. Rev. Microbiol. 57, 441–466. 10.1146/annurev.micro.57.030502.090913 [DOI] [PubMed] [Google Scholar]
  35. Gruber T. M., Markov D., Sharp M. M., Young B. A., Lu C. Z., Zhong H. J., et al. (2001). Binding of the initiation factor sigma to core RNA polymerase is a multistep process. Mol. Cell 8, 21–31. 10.1016/S1097-2765(01)00292-1 [DOI] [PubMed] [Google Scholar]
  36. Gulten G., Sacchettini J. C. (2013). Structure of the Mtb CarD/RNAP beta-lobes complex reveals the molecular basis of interaction and presents a distinct DNA-binding domain for Mtb CarD. Structure 21, 1859–1869. 10.1016/j.str.2013.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Haugen S. P., Berkmen M. B., Ross W., Gaal T., Ward C., Gourse R. L. (2006). rRNA promoter regulation by nonoptimal binding of sigma region 1.2: an additional recognition element for RNA polymerase. Cell 125, 1069–1082. 10.1016/j.cell.2006.04.034 [DOI] [PubMed] [Google Scholar]
  38. Haugen S. P., Ross W., Gourse R. L. (2008). Advances in bacterial promoter recognition and its control by factors that do not bind DNA. Nat. Rev. Microbiol. 6, 507–519. 10.1038/nrmicro1912 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Hook-Barnard I. G., Hinton D. M. (2007). Transcription initiation by mix and match elements: flexibility for polymerase binding to bacterial promoters. Gene Regul. Syst. Bio. 1, 275–293. [PMC free article] [PubMed] [Google Scholar]
  40. Hudson B. P., Quispe J., Lara-González S., Kim Y., Berman H. M., Arnold E., et al. (2009). Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc. Natl. Acad. Sci. U.S.A. 106, 19830–19835. 10.1073/pnas.0908782106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Imashimizu M., Shimamoto N., Oshima T., Kashlev M. (2014). Transcription elongation: heterogeneous tracking of RNA polymerase and its biological implications. Transcription 5:e28285. 10.4161/trns.28285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jovanovic M., Burrows P. C., Bose D., Cámara B., Wiesler S., Zhang X., et al. (2011). Activity map of the Escherichia coli RNA polymerase bridge helix. J. Biol. Chem. 286, 14469–14479. 10.1074/jbc.M110.212902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kamarthapu V., Epshtein V., Benjamin B., Proshkin S., Mironov A., Cashel M., et al. (2016). ppGpp couples transcription to DNA repair in E. coli. Science 352, 993–996. 10.1126/science.aad6945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kapanidis A. N., Margeat E., Ho S. O., Kortkhonjia E., Weiss S., Ebright R. H. (2006). Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism. Science 314, 1144–1147. 10.1126/science.1131399 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Keilty S., Rosenberg M. (1987). Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J. Biol. Chem. 262, 6389–6395. [PubMed] [Google Scholar]
  46. Kireeva M., Kashlev M., Burton Z. F. (2010). Translocation by multi-subunit RNA polymerases. Biochim. Biophys. Acta 1799, 389–401. 10.1016/j.bbagrm.2010.01.007 [DOI] [PubMed] [Google Scholar]
  47. Kriner M. A., Sevostyanova A., Groisman E. A. (2016). Learning from the Leaders: gene regulation by the transcription termination factor Rho. Trends Biochem. Sci. 41, 690–699. 10.1016/j.tibs.2016.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kulbachinskiy A., Mustaev A. (2006). Region 3.2 of the sigma subunit contributes to the binding of the 3′-initiating nucleotide in the RNA polymerase active center and facilitates promoter clearance during initiation. J. Biol. Chem. 281, 18273–18276. 10.1074/jbc.C600060200 [DOI] [PubMed] [Google Scholar]
  49. Landick R. (2006). The regulatory roles and mechanism of transcriptional pausing. Biochem. Soc. Trans. 34(Pt 6), 1062–1066. 10.1042/BST0341062 [DOI] [PubMed] [Google Scholar]
  50. Lawson C. L., Swigon D., Murakami K. S., Darst S. A., Berman H. M., Ebright R. H. (2004). Catabolite activator protein: DNA binding and transcription activation. Curr. Opin. Struct. Biol. 14, 10–20. 10.1016/j.sbi.2004.01.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lee D. J., Minchin S. D., Busby S. J. (2012). Activating transcription in bacteria. Annu. Rev. Microbiol. 66, 125–152. 10.1146/annurev-micro-092611-150012 [DOI] [PubMed] [Google Scholar]
  52. Lim H. M., Lee H. J., Roy S., Adhya S. (2001). A “master” in base unpairing during isomerization of a promoter upon RNA polymerase binding. Proc. Natl. Acad. Sci. U.S.A. 98, 14849–14852. 10.1073/pnas.261517398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Liu B., Zuo Y., Steitz T. A. (2015). Structural basis for transcription reactivation by RapA. Proc. Natl. Acad. Sci. U.S.A. 112, 2006–2010. 10.1073/pnas.1417152112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Liu B., Zuo Y., Steitz T. A. (2016). Structures of E. coli sigmaS-transcription initiation complexes provide new insights into polymerase mechanism. Proc. Natl. Acad. Sci. U.S.A. 113, 4051–4056. 10.1073/pnas.1520555113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Liu M., Tolstorukov M., Zhurkin V., Garges S., Adhya S. (2004). A mutant spacer sequence between −35 and −10 elements makes the Plac promoter hyperactive and cAMP receptor protein-independent. Proc. Natl. Acad. Sci. U.S.A. 101, 6911–6916. 10.1073/pnas.0401929101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ma C., Yang X., Kandemir H., Mielczarek M., Johnston E. B., Griffith R., et al. (2013). Inhibitors of bacterial transcription initiation complex formation. ACS Chem. Biol. 8, 1972–1980. 10.1021/cb400231p [DOI] [PubMed] [Google Scholar]
  57. Ma C., Yang X., Lewis P. J. (2016). Bacterial transcription as a target for antibacterial drug development. Microbiol. Mol. Biol. Rev. 80, 139–160. 10.1128/MMBR.00055-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Maeda H., Fujita N., Ishihama A. (2000). Competition among seven Escherichia coli sigma subunits: relative binding affinities to the core RNA polymerase. Nucleic Acids Res. 28, 3497–3503. 10.1093/nar/28.18.3497 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Malinen A. M., Nandymazumdar M., Turtola M., Malmi H., Grocholski T., Artsimovitch I., et al. (2014). CBR antimicrobials alter coupling between the bridge helix and the beta subunit in RNA polymerase. Nat. Commun. 5, 3408. 10.1038/ncomms4408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Malinen A. M., Turtola M., Parthiban M., Vainonen L., Johnson M. S., Belogurov G. A. (2012). Active site opening and closure control translocation of multisubunit RNA polymerase. Nucleic Acids Res. 40, 7442–7451. 10.1093/nar/gks383 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Mekler V., Kortkhonjia E., Mukhopadhyay J., Knight J., Revyakin A., Kapanidis A. N., et al. (2002). Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex. Cell 108, 599–614. 10.1016/S0092-8674(02)00667-0 [DOI] [PubMed] [Google Scholar]
  62. Molodtsov V., Fleming P. R., Eyermann C. J., Ferguson A. D., Foulk M. A., McKinney D. C., et al. (2015). X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein. J. Med. Chem. 58, 3156–3171. 10.1021/acs.jmedchem.5b00050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Molodtsov V., Nawarathne I. N., Scharf N. T., Kirchhoff P. D., Showalter H. D., Garcia G. A., et al. (2013). X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins. J. Med. Chem. 56, 4758–4763. 10.1021/jm4004889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Morichaud Z., Chaloin L., Brodolin K. (2016). Regions 1.2 and 3.2 of the RNA Polymerase sigma subunit promote DNA melting and attenuate action of the antibiotic lipiarmycin. J. Mol. Biol. 428, 463–476. 10.1016/j.jmb.2015.12.017 [DOI] [PubMed] [Google Scholar]
  65. Mukhopadhyay J., Das K., Ismail S., Koppstein D., Jang M., Hudson B., et al. (2008). The RNA polymerase “switch region” is a target for inhibitors. Cell 135, 295–307. 10.1016/j.cell.2008.09.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Mukhopadhyay J., Sineva E., Knight J., Levy R. M., Ebright R. H. (2004). Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol. Cell 14, 739–751. 10.1016/j.molcel.2004.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Murakami K. S. (2013). X-ray crystal structure of Escherichia coli RNA polymerase sigma70 holoenzyme. J. Biol. Chem. 288, 9126–9134. 10.1074/jbc.M112.430900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Murakami K. S. (2015). Structural biology of bacterial RNA polymerase. Biomolecules 5, 848–864. 10.3390/biom5020848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Murakami K. S., Darst S. A. (2003). Bacterial RNA polymerases: the wholo story. Curr. Opin. Struct. Biol. 13, 31–39. 10.1016/S0959-440X(02)00005-2 [DOI] [PubMed] [Google Scholar]
  70. Murakami K. S., Masuda S., Campbell E. A., Muzzin O., Darst S. A. (2002a). Structural basis of transcription initiation: an RNA polymerase holoenzyme-DNA complex. Science 296, 1285–1290. 10.1126/science.1069595 [DOI] [PubMed] [Google Scholar]
  71. Murakami K. S., Masuda S., Darst S. A. (2002b). Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 A resolution. Science 296, 1280–1284. 10.1126/science.1069594 [DOI] [PubMed] [Google Scholar]
  72. Niu W., Kim Y., Tau G., Heyduk T., Ebright R. H. (1996). Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell 87, 1123–1134. 10.1016/S0092-8674(00)81806-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Nudler E. (2009). RNA polymerase active center: the molecular engine of transcription. Annu. Rev. Biochem. 78, 335–361. 10.1146/annurev.biochem.76.052705.164655 [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Nudler E. (2012). RNA polymerase backtracking in gene regulation and genome instability. Cell 149, 1438–1445. 10.1016/j.cell.2012.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Patrick M., Dennis P. P., Ehrenberg M., Bremer H. (2015). Free RNA polymerase in Escherichia coli. Biochimie 119, 80–91. 10.1016/j.biochi.2015.10.015 [DOI] [PubMed] [Google Scholar]
  76. Perdue S. A., Roberts J. W. (2011). Sigma(70)-dependent transcription pausing in Escherichia coli. J. Mol. Biol. 412, 782–792. 10.1016/j.jmb.2011.02.011 [DOI] [PubMed] [Google Scholar]
  77. Pupov D., Kuzin I., Bass I., Kulbachinskiy A. (2014). Distinct functions of the RNA polymerase sigma subunit region 3.2 in RNA priming and promoter escape. Nucleic Acids Res. 42, 4494–4504. 10.1093/nar/gkt1384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Revyakin A., Liu C., Ebright R. H., Strick T. R. (2006). Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching. Science 314, 1139–1143. 10.1126/science.1131398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Rhodius V. A., Busby S. J. (2000). Transcription activation by the Escherichia coli cyclic AMP receptor protein: determinants within activating region 3. J. Mol. Biol. 299, 295–310. 10.1006/jmbi.2000.3736 [DOI] [PubMed] [Google Scholar]
  80. Rhodius V. A., West D. M., Webster C. L., Busby S. J., Savery N. J. (1997). Transcription activation at class II CRP-dependent promoters: the role of different activating regions. Nucleic Acids Res. 25, 326–332. 10.1093/nar/25.2.326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Robb N. C., Cordes T., Hwang L. C., Gryte K., Duchi D., Craggs T. D., et al. (2013). The transcription bubble of the RNA polymerase-promoter open complex exhibits conformational heterogeneity and millisecond-scale dynamics: implications for transcription start-site selection. J. Mol. Biol. 425, 875–885. 10.1016/j.jmb.2012.12.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Roberts J., Park J. S. (2004). Mfd, the bacterial transcription repair coupling factor: translocation, repair and termination. Curr. Opin. Microbiol. 7, 120–125. 10.1016/j.mib.2004.02.014 [DOI] [PubMed] [Google Scholar]
  83. Ross W., Ernst A., Gourse R. L. (2001). Fine structure of E. coli RNA polymerase-promoter interactions: alpha subunit binding to the UP element minor groove. Genes Dev. 15, 491–506. 10.1101/gad.870001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Ross W., Gosink K. K., Salomon J., Igarashi K., Zou C., Ishihama A., et al. (1993). A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science 262, 1407–1413. 10.1126/science.8248780 [DOI] [PubMed] [Google Scholar]
  85. Ross W., Gourse R. L. (2009). Analysis of RNA polymerase-promoter complex formation. Methods 47, 13–24. 10.1016/j.ymeth.2008.10.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Roy S., Garges S., Adhya S. (1998). Activation and repression of transcription by differential contact: two sides of a coin. J. Biol. Chem. 273, 14059–14062. 10.1074/jbc.273.23.14059 [DOI] [PubMed] [Google Scholar]
  87. Saecker R. M., Record M. T., Jr., Dehaseth P. L. (2011). Mechanism of bacterial transcription initiation: RNA polymerase - promoter binding, isomerization to initiation-competent open complexes, and initiation of RNA synthesis. J. Mol. Biol. 412, 754–771. 10.1016/j.jmb.2011.01.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Samanta S., Martin C. T. (2013). Insights into the mechanism of initial transcription in Escherichia coli RNA polymerase. J. Biol. Chem. 288, 31993–32003. 10.1074/jbc.M113.497669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Sarkar P., Sardesai A. A., Murakami K. S., Chatterji D. (2013). Inactivation of the bacterial RNA polymerase due to acquisition of secondary structure by the omega subunit. J. Biol. Chem. 288, 25076–25087. 10.1074/jbc.M113.468520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Sen R., Nagai H., Hernandez V. J., Shimamoto N. (1998). Reduction in abortive transcription from the lambdaPR promoter by mutations in region 3 of the sigma70 subunit of Escherichia coli RNA polymerase. J. Biol. Chem. 273, 9872–9877. 10.1074/jbc.273.16.9872 [DOI] [PubMed] [Google Scholar]
  91. Sengupta S., Prajapati R. K., Mukhopadhyay J. (2015). Promoter Escape with bacterial two-component sigma factor suggests retention of sigma region two in the elongation complex. J. Biol. Chem. 290, 28575–28583. 10.1074/jbc.M115.666008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Sharp M. M., Chan C. L., Lu C. Z., Marr M. T., Nechaev S., Merritt E. W., et al. (1999). The interface of sigma with core RNA polymerase is extensive, conserved, and functionally specialized. Genes Dev. 13, 3015–3026. 10.1101/gad.13.22.3015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Shorenstein R. G., Losick R. (1973). Purification and properties of the sigma subunit of ribonucleic acid polymerase from vegetative Bacillus subtilis. J. Biol. Chem. 248, 6163–6169. [PubMed] [Google Scholar]
  94. Shultzaberger R. K., Chen Z., Lewis K. A., Schneider T. D. (2007). Anatomy of Escherichia coli sigma70 promoters. Nucleic Acids Res. 35, 771–788. 10.1093/nar/gkl956 [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Srivastava A., Talaue M., Liu S., Degen D., Ebright R. Y., Sineva E., et al. (2011). New target for inhibition of bacterial RNA polymerase: ‘switch region.’ Curr. Opin. Microbiol. 14, 532–543. 10.1016/j.mib.2011.07.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Srivastava D. B., Leon K., Osmundson J., Garner A. L., Weiss L. A., Westblade L. F., et al. (2013). Structure and function of CarD, an essential mycobacterial transcription factor. Proc. Natl. Acad. Sci. U.S.A. 110, 12619–12624. 10.1073/pnas.1308270110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Stallings C. L., Stephanou N. C., Chu L., Hochschild A., Nickels B. E., Glickman M. S. (2009). CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence. Cell 138, 146–159. 10.1016/j.cell.2009.04.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Svetlov V., Nudler E. (2009). Macromolecular micromovements: how RNA polymerase translocates. Curr. Opin. Struct. Biol. 19, 701–707. 10.1016/j.sbi.2009.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Temiakov D., Zenkin N., Vassylyeva M. N., Perederina A., Tahirov T. H., Kashkina E., et al. (2005). Structural basis of transcription inhibition by antibiotic streptolydigin. Mol. Cell 19, 655–666. 10.1016/j.molcel.2005.07.020 [DOI] [PubMed] [Google Scholar]
  100. Tupin A., Gualtieri M., Leonetti J. P., Brodolin K. (2010). The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site. EMBO J. 29, 2527–2537. 10.1038/emboj.2010.135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Tuske S., Sarafianos S. G., Wang X., Hudson B., Sineva E., Mukhopadhyay J., et al. (2005). Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell 122, 541–552. 10.1016/j.cell.2005.07.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Vassylyev D. G., Sekine S., Laptenko O., Lee J., Vassylyeva M. N., Borukhov S., et al. (2002). Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 A resolution. Nature 417, 712–719. 10.1038/nature752 [DOI] [PubMed] [Google Scholar]
  103. Vassylyev D. G., Vassylyeva M. N., Zhang J., Palangat M., Artsimovitch I., Landick R. (2007). Structural basis for substrate loading in bacterial RNA polymerase. Nature 448, 163–168. 10.1038/nature05931 [DOI] [PubMed] [Google Scholar]
  104. Vvedenskaya I. O., Vahedian-Movahed H., Zhang Y., Taylor D. M., Ebright R. H., Nickels B. E. (2016). Interactions between RNA polymerase and the core recognition element are a determinant of transcription start site selection. Proc. Natl. Acad. Sci. U.S.A. 113, E2899–E2905. 10.1073/pnas.1603271113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Vvedenskaya I. O., Zhang Y., Goldman S. R., Valenti A., Visone V., Taylor D. M., et al. (2015). Massively systematic transcript end readout, “MASTER”: transcription start site selection, transcriptional slippage, and transcript yields. Mol. Cell 60, 953–965. 10.1016/j.molcel.2015.10.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Wang D., Bushnell D. A., Westover K. D., Kaplan C. D., Kornberg R. D. (2006). Structural basis of transcription: role of the trigger loop in substrate specificity and catalysis. Cell 127, 941–954. 10.1016/j.cell.2006.11.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Winkelman J. T., Chandrangsu P., Ross W., Gourse R. L. (2016a). Open complex scrunching before nucleotide addition accounts for the unusual transcription start site of E. coli ribosomal RNA promoters. Proc. Natl. Acad. Sci. U.S.A. 113, E1787–E1795. 10.1073/pnas.1522159113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Winkelman J. T., Vvedenskaya I. O., Zhang Y., Zhang Y., Bird J. G., Taylor D. M., et al. (2016b). Multiplexed protein-DNA cross-linking: Scrunching in transcription start site selection. Science 351, 1090–1093. 10.1126/science.aad6881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Winkelman J. T., Winkelman B. T., Boyce J., Maloney M. F., Chen A. Y., Ross W., et al. (2015). Crosslink mapping at amino acid-base resolution reveals the path of scrunched DNA in initial transcribing complexes. Mol. Cell 59, 768–780. 10.1016/j.molcel.2015.06.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Yang X., Ma C., Lewis P. J. (2015a). Identification of inhibitors of bacterial RNA polymerase. Methods 86, 45–50. 10.1016/j.ymeth.2015.05.005 [DOI] [PubMed] [Google Scholar]
  111. Yang Y., Darbari V. C., Zhang N., Lu D., Glyde R., Wang Y. P., et al. (2015b). TRANSCRIPTION. Structures of the RNA polymerase-sigma54 reveal new and conserved regulatory strategies. Science 349, 882–885. 10.1126/science.aab1478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Yarnell W. S., Roberts J. W. (1999). Mechanism of intrinsic transcription termination and antitermination. Science 284, 611–615. 10.1126/science.284.5414.611 [DOI] [PubMed] [Google Scholar]
  113. Yuzenkova Y., Roghanian M., Bochkareva A., Zenkin N. (2013). Tagetitoxin inhibits transcription by stabilizing pre-translocated state of the elongation complex. Nucleic Acids Res. 41, 9257–9265. 10.1093/nar/gkt708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Yuzenkova Y., Tadigotla V. R., Severinov K., Zenkin N. (2011). A new basal promoter element recognized by RNA polymerase core enzyme. EMBO J. 30, 3766–3775. 10.1038/emboj.2011.252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Zhang G., Campbell E. A., Minakhin L., Richter C., Severinov K., Darst S. A. (1999). Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution. Cell 98, 811–824. 10.1016/S0092-8674(00)81515-9 [DOI] [PubMed] [Google Scholar]
  116. Zhang Y., Degen D., Ho M. X., Sineva E., Ebright K. Y., Ebright Y. W., et al. (2014). GE23077 binds to the RNA polymerase ‘i’ and ‘i+1’ sites and prevents the binding of initiating nucleotides. Elife 3:e02450. 10.7554/eLife.02450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Zhang Y., Feng Y., Chatterjee S., Tuske S., Ho M. X., Arnold E., et al. (2012). Structural basis of transcription initiation. Science 338, 1076–1080. 10.1126/science.1227786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Zuo Y., Steitz T. A. (2015). Crystal structures of the E. coli transcription initiation complexes with a complete bubble. Mol. Cell 58, 534–540. 10.1016/j.molcel.2015.03.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Zuo Y., Wang Y., Steitz T. A. (2013). The mechanism of E. coli RNA polymerase regulation by ppGpp is suggested by the structure of their complex. Mol. Cell 50, 430–436. 10.1016/j.molcel.2013.03.020 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Molecular Biosciences are provided here courtesy of Frontiers Media SA

RESOURCES